PRVA
Privia Health Group, Inc. Common Stock
SERVICES-HEALTH SERVICES
Best Health Services Stocks 2026 →
Privia Health Group (PRVA) Stock: Buy, Sell, or Hold?
$24.37
-0.17 (-0.69%)
▼
5d:
+13.51%
30d:
+13.61%
90d:
+13.14%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (25%)
Quality Score
35/100
Position
EXTENDED
30-Day Fair Range
$20.69 – $23.08
Position: EXTENDED
Forward P/E & Valuation
23.7x
FAIR
vs 20.8x historical avg
Wall Street Target
$31.35
+28.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$20.74 / $24.96
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: PRVA shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When PRVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.21
Based on 12.5% avg growth
INTRINSIC VALUE TODAY
$23.73
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PRVA is currently trading at $24.37, which is considered extended relative to its 30-day fair value range of $20.69 to $23.08. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.7) compared to its historical average (20.8). At these levels, the market is pricing in 4.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PRVA is in a strong downtrend. The price is approaching resistance at $24.96. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRVA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.35 (+28.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRVA is in a strong downtrend. The price is approaching resistance at $24.96. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRVA scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $31.35 (+28.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.69 -
$23.08
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
24.8%
Trading Range & Key Levels
30-Day Trading Range
$20.69 -
$23.08
Current vs Trading Range
EXTENDED
Support Level
$20.74
Resistance Level
$24.96
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
PRVA is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range (+5.6% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.7% below Wall St target ($31.35)
- NEUTRAL: Market pricing in 4.4% annual earnings growth - fairly valued
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
23.68
Wall Street Target
$31.35
(+28.7%)
Revenue Growth (YoY)
13.2%
Earnings Growth (YoY)
100.0%
Profit Margin
1.4%
Valuation Premium vs History
+4.4% premium
PE vs Historical
23.7 vs 20.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.4%
(market-implied from PE analysis)
1-Year Target
$25.44
(+4%)
2-Year Target
$26.56
(+9%)
3-Year Target
$27.73
(+14%)
3-Yr Target (if PE normalizes)
(PE: 24→21)
PE COMPRESSION
$24.35
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.7, Growth: 20.9%)
$43.08
(+77%)
Base:
(SPY PE: 19.9, Growth: 20.9%)
$36.13
(+48%)
Bear:
(PE: 16.9, Growth: 20.9%)
$30.71
(+26%)
📈
Valuation based on Current Earnings
Forward PE: 22.12 | Forward EPS (Implied): $1.10
Bull Case
$29.43
(+21%)
Analyst growth 15.0%, PE expands to 23.2
Base Case
$24.37
(0%)
Market implied 0.0%, PE stable at 22.1
Bear Case
$18.64
(-24%)
Severe decline -15.0%, PE contracts to 19.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share PRVA Analysis
Share this live PRVA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PRVA)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jun 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Privia Health (PRVA) reported stronger-than-expected Q1 revenues, up 25.8% YoY, but missed EPS estimates, leading to a post-earnings stock decline. The healthcare technology provider, which helps physicians optimize their practices and transition to value-based care models, serves over 4.8 million patients across 13 states and DC.
Key Retail Themes:
Strong Q1 revenues
Mixed earnings report
Value-based care models
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 8:58 PM ET
Data refreshes hourly during market hours. Next update: 9:58 PM
Data refreshes hourly during market hours. Next update: 9:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRVA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$320 | 48 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$35 | 35 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$83 | 35 SELL |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$135 | 40 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
15 analysts |
$121 | 42 HOLD |
Advanced PRVA Option Strategies
Professional options setups generated by AI based on today's PRVA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRVA Research Pages
